Advertisement

Behavioral Neurobiology of Anxiety and Its Treatment

  • Murray B. Stein
  • Thomas Steckler

Part of the Current Topics in Behavioral Neurosciences book series (CTBN, volume 2)

Table of contents

  1. Front Matter
    Pages i-xv
  2. O. Joseph Bienvenu, Lisa A. Wuyek, Murray B. Stein
    Pages 3-19
  3. Ronald C. Kessler, Ayelet Meron Ruscio, Katherine Shear, Hans-Ulrich Wittchen
    Pages 21-35
  4. Kathleen Ries Merikangas, Sonja Alsemgeest Swanson
    Pages 37-59
  5. Katharina Domschke, Jürgen Deckert
    Pages 63-75
  6. Newton Sabino Canteras, Leonardo Barbosa Resstel, Leandro José Bertoglio, Antonio de Pádua Carobrez, Francisco Silveira Guimarães
    Pages 77-96
  7. Pêgo J. M, Sousa J. C, Almeida OFX, Sousa N
    Pages 97-118
  8. Dallas Treit, Elif Engin, Kris McEown
    Pages 121-160
  9. Laura H. Jacobson, John F. Cryan
    Pages 161-201
  10. Victoria Risbrough
    Pages 205-228
  11. M. A. Van Duinen, V. Niccolai, E. J. L. Griez
    Pages 229-250
  12. Dennis C. Choi, Barbara O. Rothbaum, Maryrose Gerardi, Kerry J. Ressler
    Pages 279-299
  13. C. Durant, D. Christmas, D. Nutt
    Pages 303-330
  14. Anton Y. Bespalov, Marcel M. van Gaalen, Gerhard Gross
    Pages 361-390
  15. Will Spooren, Anne Lesage, Hilde Lavreysen, Fabrizio Gasparini, Thomas Steckler
    Pages 391-413
  16. Fabrício A. Moreira, Carsten T. Wotjak
    Pages 429-450
  17. David S. Baldwin, Khalil I. Ajel, Matthew Garner
    Pages 453-467
  18. Murray Stein, Thomas Steckler, Jeffrey D. Lightfoot, Elizabeth Hay, Andrew W. Goddard
    Pages 469-485
  19. Keith A. Ganasen, Dan J. Stein
    Pages 487-503
  20. Lakshmi N. Ravindran, Murray B. Stein
    Pages 505-525
  21. Back Matter
    Pages 545-554

About this book

Introduction

The book is part of a series on Current Topics in Behavioral Neurosciences, which has as its focus anxiety and its treatment. We have brought together a distinguished cadre of authors with the aim of covering a broad array of topics related to anxiety disorders, ranging from clinical diagnosis, epidemiology, preclinical neuroscience, and animal models to established and innovative therapeutic approaches. The book aims at bridging these disciplines to provide an update of literature relevant to understanding anxiety, its consequences, and its management. Following is a brief overview of the chapters and their content, meant to serve as a guide to navigating the book. The ?rst section covers clinical aspects of anxiety disorders. Joe Bienvenu and colleagues provide an incisive overview of diagnostic considerations in the anxiety disorders in which they emphasize the strengths and shortcomings of our current nosologic systems. This is followed by a review and update of the epidemiology of anxiety disorders by Ron Kessler and colleagues, which provides an authoritative survey of anxiety disorder incidence, prevalence, and risk factors. This is comp- mented by a comprehensive review of the literature on disorders that co-occur with anxiety disorders by Kathleen Merikangas and Sonja Alsemgeest Swanson. Their review highlights the tremendous comorbidity that occurs not only within the anxiety disorders, but also with other mental and physical health conditions.

Keywords

Cannabinoid Neurobiology anatomy anxiety diagnosis genetics neuroimaging

Editors and affiliations

  • Murray B. Stein
    • 1
  • Thomas Steckler
    • 2
  1. 1.Dept. PsychiatryUniversity of California, San DiegoLa JollaUSA
  2. 2.Research & Development, CNS - Affective SpectrumJohnson & Johnson PharmaceuticalBeerseBelgium

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-02912-7
  • Copyright Information Springer-Verlag Berlin Heidelberg 2010
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Biomedical and Life Sciences
  • Print ISBN 978-3-642-02911-0
  • Online ISBN 978-3-642-02912-7
  • Series Print ISSN 1866-3370
  • Series Online ISSN 1866-3389
  • Buy this book on publisher's site
Industry Sectors
Pharma
Biotechnology
Consumer Packaged Goods